Guardian Pharmacy Services (NYSE:GRDN) Upgraded to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Guardian Pharmacy Services (NYSE:GRDN) from a hold rating to a buy rating in a research report sent to investors on Sunday morning.

GRDN has been the topic of several other research reports. Oppenheimer lifted their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday. Truist Financial increased their price target on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Bank of America boosted their price objective on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday. Finally, Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $43.83.

Guardian Pharmacy Services Stock Down 1.1%

Shares of Guardian Pharmacy Services stock opened at $43.35 on Friday. Guardian Pharmacy Services has a 12 month low of $19.30 and a 12 month high of $47.02. The stock has a market cap of $2.16 billion, a PE ratio of 42.09, a price-to-earnings-growth ratio of 2.87 and a beta of 0.11. The business has a fifty day simple moving average of $40.93 and a 200-day simple moving average of $37.16.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.03. The firm had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. Analysts expect that Guardian Pharmacy Services will post 1.18 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of GRDN. Dynamic Technology Lab Private Ltd bought a new position in shares of Guardian Pharmacy Services during the 1st quarter valued at $233,000. JPMorgan Chase & Co. increased its position in Guardian Pharmacy Services by 48.0% during the second quarter. JPMorgan Chase & Co. now owns 6,027 shares of the company’s stock worth $128,000 after buying an additional 1,956 shares during the last quarter. Legal & General Group Plc increased its position in Guardian Pharmacy Services by 1,783.1% during the second quarter. Legal & General Group Plc now owns 14,895 shares of the company’s stock worth $317,000 after buying an additional 14,104 shares during the last quarter. Rhumbline Advisers increased its position in Guardian Pharmacy Services by 121.1% during the second quarter. Rhumbline Advisers now owns 16,174 shares of the company’s stock worth $345,000 after buying an additional 8,860 shares during the last quarter. Finally, Quantbot Technologies LP bought a new position in Guardian Pharmacy Services during the second quarter valued at about $214,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.